This resolution supports the designation of November 2022 as National Alpha-1 Antitrypsin Deficiency Awareness Month. Alpha-1 antitrypsin deficiency is a genetic disease that increases the risk of harm to the lungs, liver, skin, and blood vessels.
Get AI-generated questions to help you understand this bill better
Timeline
Introduced in Senate
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4973)
Introduced in Senate
Referred to the Committee on Health, Education, Labor, and Pensions. (text: CR S4973)
Health
A resolution expressing support for the designation of November 2022 as "National Alpha-1 Antitrypsin Deficiency Awareness Month".
USA117th CongressSRES-792| Senate
| Updated: 9/22/2022
This resolution supports the designation of November 2022 as National Alpha-1 Antitrypsin Deficiency Awareness Month. Alpha-1 antitrypsin deficiency is a genetic disease that increases the risk of harm to the lungs, liver, skin, and blood vessels.